Intervention

anti-CEA CAR-T cells

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions8

Lead sponsors shown2

Clinical trials

3 shown

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)NCT03682744 · 2018-09-13

CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas CancerNCT02850536 · 2017-02-01

CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver MetastasesNCT02416466 · 2015-04-01

Common conditions

Liver Metastases2 Breast Cancer1 Carcinoembryonic Antigen1 Colorectal Cancer1 Gastric Cancer1 Pancreas Cancer1 Peritoneal Carcinomatosis1 Peritoneal Metastases1

Leading sponsors

Roger Williams Medical Center2 Sorrento Therapeutics, Inc.1

Trial status mix

COMPLETED2

WITHDRAWN1

Phase mix

PHASE13

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.